Skip to content

SmartManage Stress Management for HIV+ Cancer Survivors

Development of an eHealth-based Cognitive Behavioral Stress and Self-Management Intervention to Reduce Symptom Burden in HIV+ Gay and Bisexual Men Who Have Sex With Men (MSM) Treated for Non-Metastatic Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04544917
Enrollment
32
Registered
2020-09-10
Start date
2021-02-15
Completion date
2024-09-03
Last updated
2025-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Hiv, Stress

Keywords

Symptom burden, Cognitive behavioral stress management, Intervention development

Brief summary

The purpose of this study is to design and refine a web-based platform developed for managing symptom burden in men who have sex who are HIV+ cancer survivors.

Interventions

BEHAVIORALSmartManage for HIV+ cancer survivors

Ten weekly therapist delivered group sessions delivered via web conference. Sessions focus on cognitive behavioral stress management, psychoeducation, and management strategies for dual diagnosis of HIV and cancer. Participants will have access to the SmartManage web platform which has all intervention material, resources, and exercises.

Participants in the control condition will view ten videos over ten weeks, consisting of informational and educational material relevant to cancer and HIV.

Sponsors

American Cancer Society, Inc.
CollaboratorOTHER
University of Miami
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age: 18 years or older 2. Fluent in English 3. Have evidence of at least one form of non-metastatic solid tumor cancer or blood cancer 4. Be at least 30 days post active primary cancer treatment 5. Self identify as a sexual minority cisgender man 6. Self-report having been diagnosed with HIV 7. Have reliable access to a computer/device with internet accessibility

Exclusion criteria

1. Have had one of the following exclusionary cancer types: Non-melanoma skin cancer, brain cancer, eye cancer, history of some form of pediatric cancer (if that is participant's only cancer diagnosis) 2. History of advanced (metastatic) cancer of any type 3. Inpatient treatment for severe mental illness in the past 12 months and/or suicidality of moderate or greater risk 4. Appears actively intoxicated or otherwise unable to provide full informed consent 5. Have any other medical condition resulting in predicted live expectancy of less than 12 months

Design outcomes

Primary

MeasureTime frameDescription
Proportion of eligible SMM that agree to participateUp to one yearFeasibility of the intervention will be reported as the proportion of eligible sexual minority men (SMM) who agree to participate versus decline

Secondary

MeasureTime frameDescription
USE Questionnaire ScoresWeek 10Acceptability of the intervention will be reported as Usefulness, Satisfaction and Ease of Use (USE) Questionnaire Scores. USE is a 30-item questionnaire with a total score ranging from 30-240 with the higher score indicating greater acceptability of the intervention.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026